ATE355087T1 - Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman - Google Patents

Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman

Info

Publication number
ATE355087T1
ATE355087T1 AT01998107T AT01998107T ATE355087T1 AT E355087 T1 ATE355087 T1 AT E355087T1 AT 01998107 T AT01998107 T AT 01998107T AT 01998107 T AT01998107 T AT 01998107T AT E355087 T1 ATE355087 T1 AT E355087T1
Authority
AT
Austria
Prior art keywords
hydrophilic
hydroxy
chromane
stabilization
thioether
Prior art date
Application number
AT01998107T
Other languages
English (en)
Inventor
John E Cyr
Daniel A Pearson
Original Assignee
Cis Bio Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cis Bio Int filed Critical Cis Bio Int
Application granted granted Critical
Publication of ATE355087T1 publication Critical patent/ATE355087T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Dispersion Chemistry (AREA)
  • Optics & Photonics (AREA)
  • Epidemiology (AREA)
  • Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
AT01998107T 2000-10-24 2001-10-24 Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman ATE355087T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US69536000A 2000-10-24 2000-10-24
US69499200A 2000-10-24 2000-10-24
US69549400A 2000-10-24 2000-10-24

Publications (1)

Publication Number Publication Date
ATE355087T1 true ATE355087T1 (de) 2006-03-15

Family

ID=27418608

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998107T ATE355087T1 (de) 2000-10-24 2001-10-24 Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman

Country Status (12)

Country Link
US (1) US20040058984A1 (de)
EP (2) EP1808184A3 (de)
JP (1) JP4236468B2 (de)
AT (1) ATE355087T1 (de)
AU (1) AU2002249863A1 (de)
CA (1) CA2426587A1 (de)
CY (1) CY1106622T1 (de)
DE (1) DE60126994T2 (de)
DK (1) DK1381397T3 (de)
ES (1) ES2282326T3 (de)
PT (1) PT1381397E (de)
WO (1) WO2002060491A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050090551A1 (en) * 2003-10-27 2005-04-28 Board Of Trustees Of Southern Illinois University Therapeutic use of methionine for the treatment or prevention of mucositis
EA038941B1 (ru) * 2007-11-06 2021-11-12 ПиТиСи ТЕРАПЬЮТИКС, ИНК. ПРОИЗВОДНЫЕ 4-(п-ХИНОНИЛ)-2-ГИДРОКСИБУТАНАМИДА ДЛЯ ЛЕЧЕНИЯ МИТОХОНДРИАЛЬНЫХ ЗАБОЛЕВАНИЙ
CN103599541A (zh) * 2008-09-10 2014-02-26 弗·哈夫曼-拉罗切有限公司 用于防止蛋白质氧化降解的组合物和方法
WO2012055992A2 (en) * 2010-10-28 2012-05-03 Ge Healthcare Limited Stabilisation of radiopharmaceutical precursors
DK2694095T3 (en) 2011-04-05 2018-05-28 Longevity Biotech Inc COMPOSITIONS COMPREHENSIVE GLUCAGON ANALOGS AND METHODS FOR PREPARING AND USING THE SAME
WO2014145718A2 (en) 2013-03-15 2014-09-18 Longevity Biotech, Inc. Peptides comprising non-natural amino acids and methods of making and using the same
SG11201507769SA (en) 2013-03-29 2015-10-29 Glytech Inc Polypeptide having sialylated sugar chains attached thereto
WO2018075564A1 (en) 2016-10-17 2018-04-26 University Of Maryland, College Park Multispecific antibodies targeting human immunodeficiency virus and methods of using the same
EP3549946A4 (de) * 2016-11-29 2020-10-21 Spiber Inc. Proteinzusammensetzung, verfahren zur herstellung davon und verfahren zur verbesserung der wärmestabilität

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3476772A (en) * 1966-10-20 1969-11-04 Eastman Kodak Co Chroman derivatives of 2,5-dimethyl-2,4-hexadiene
US3986980A (en) * 1974-04-29 1976-10-19 Hoffmann-La Roche Inc. Synergistic antioxidant composition comprising ascorbic acid and 6-hydroxy-2,5,7,8-tetramethylchroman-2- carboxylic acid
JPS6094976A (ja) * 1983-10-28 1985-05-28 Sumitomo Chem Co Ltd クロマン誘導体およびその製造方法
US5393512A (en) * 1985-01-14 1995-02-28 Vanderheyden; Jean-Luc Stable therapeutic radionuclide compositions and methods for preparation thereof
DE3722647A1 (de) * 1987-07-09 1989-01-19 Gerhard Ohlenschlaeger Galenische verwendung eines tripeptids als arzneimittel
US6030950A (en) * 1987-07-09 2000-02-29 Ohlenschlaeger; Gerhard Pharmaceutical therapeutic use of glutathione derivative
US5759515A (en) * 1989-08-09 1998-06-02 Rhomed Incorporated Polyvalent peptide pharmaceutical applications
WO1993002652A2 (en) * 1991-08-01 1993-02-18 Hybritech Incorporated Modified haptens useful as imaging and therapeutic agents
JPH06228170A (ja) * 1993-02-04 1994-08-16 Noda Sangyo Kagaku Kenkyusho ホスファチジルクロマノール誘導体、その製造方法、抗酸化剤及び乳化剤
JP3051591B2 (ja) * 1993-03-05 2000-06-12 日本メジフィジックス株式会社 タリウム−２０１の容器に対する付着防止剤
JP3839071B2 (ja) * 1993-12-07 2006-11-01 有限会社ケムフィズ クロマン誘導体
EP1024165B1 (de) * 1997-10-02 2003-07-09 API Corporation Stabilisatorenzusammensetzung für organische polymermaterialien enthaltend 6-hydroxichromanverbindungen und organische polymermaterialzusammensetzungen
EP0955355A3 (de) * 1998-04-28 2000-08-02 Ciba SC Holding AG Antioxidantien zur Stabilisierung tensidhaltiger Formulierungen
US6171578B1 (en) * 1999-04-14 2001-01-09 Diatide, Inc. Benzodiazepine derivatives for imaging thrombi

Also Published As

Publication number Publication date
CA2426587A1 (en) 2002-08-08
PT1381397E (pt) 2007-05-31
AU2002249863A1 (en) 2002-08-12
DE60126994D1 (de) 2007-04-12
CY1106622T1 (el) 2012-01-25
WO2002060491A3 (en) 2003-11-06
ES2282326T3 (es) 2007-10-16
JP4236468B2 (ja) 2009-03-11
WO2002060491A2 (en) 2002-08-08
US20040058984A1 (en) 2004-03-25
DK1381397T3 (da) 2007-06-18
EP1381397B1 (de) 2007-02-28
JP2005500982A (ja) 2005-01-13
EP1381397A2 (de) 2004-01-21
EP1808184A3 (de) 2008-08-13
DE60126994T2 (de) 2007-11-15
EP1808184A2 (de) 2007-07-18

Similar Documents

Publication Publication Date Title
ATE510534T1 (de) Naltrexonhydrochlorid-zusammensetzungen
DE60235900D1 (de) Osuppressivum
PT897904E (pt) 2-metoxibenzofenonas fungicidas
ATE477813T1 (de) Erythropoietin-lösungszubereitung, stabilisiert mit leucin oder glutaminsäure
BRPI0415449A (pt) combinações de compostos ativos fungicidas sinergìsticos
NO2005015I2 (no) Terapeutisk aktiv forbindelse preparat inneholdende forbindelsen samt den anvendelse
GR3032458T3 (en) Stabilization of naloxonhydrochlorid
DK1324776T3 (da) Koncentrerede proteinformuleringer med mindsket viskositet
BR0317696A (pt) Composição para branqueamento
IL149459A0 (en) Recombinant gelatins
GEP20104997B (en) Composition comprising anther2 antibodies
UA39099C2 (uk) Циклічні азотовмісні похідні, суміш їх ізомерів або окремі ізомери, або їх солі
ES2038826T3 (es) Estabilizadores organicos.
ID26033A (id) Metode penstabilan komposisi bahan farmasi dengan penggunaan khusus dari antioksidan
BR0106649B1 (pt) composição fertilizante contendo enxofre.
MXPA05013251A (es) Composiciones para estado de oxigeno mejorado en animales de compania.
FI943724A0 (fi) Stabiloidut radiofarmaseuttiset pakkaukset
DE60126994D1 (de) Stabilisierung von radiopharmazeutischen zusammensetzungen mit einem hydrophilen thioether oder einem hydrophilen 6-hydroxy-chroman
DE60117467D1 (de) Famotidin-injektionen
DE69940551D1 (de) Mercaptane und disulfide
HUT57820A (en) Process for stabilizing 3-isothiazolones with mexamethylene tetraamine, stabilized compositions and process for utilizing them
DE69007546D1 (de) Haarbehandlungszusammensetzung.
NL194506B (nl) Samenstelling, bevattende een elastomeer en een stabilisatormengsel.
DE602004013011D1 (de) Haarbehandlungszusammensetzungen
BR0206424B1 (pt) emulsão estabilizada reversìvel e processo de controle da estabilização de uma emulsão reversìvel.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1381397

Country of ref document: EP

REN Ceased due to non-payment of the annual fee